PainChek

PainChek EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PainChek (PCK.AX) as of Oct 18, 2026 is -9.92 M AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -9.11 M AUD — a change of 8.82% (lower).

EBITDA

-9.92 MAUD

YoY

8.82%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PainChek is 2026 -9.92 M AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PainChek was 2025 -9.11 M AUD. It decreases by 8.82% lower compared to the previous year.

The PainChek EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-3.26 M AUD
Jan 1, 2020
-15.04 M AUD
Jan 1, 2021
-8.97 M AUD
Jan 1, 2022
-7.59 M AUD
Jan 1, 2023
-8.76 M AUD
Jan 1, 2024
-9.51 M AUD
Jan 1, 2025
-9.11 M AUD
Jan 1, 2026
-9.92 M AUD
The PainChek EBITDA history
YEAREBITDAYoY
-9.92 MAUD+8.82%
-9.11 MAUD-4.23%
-9.51 MAUD+8.58%
-8.76 MAUD+15.45%
-7.59 MAUD-15.38%
-8.97 MAUD-40.37%
-15.04 MAUD+361.02%
-3.26 MAUD-32.18%
-4.81 MAUD+20.11%
-4.01 MAUD+209.48%
-1.29 MAUD+38.56%
-933,976.00AUD+20.30%
-776,360.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

PainChek Stock analysis

What does PainChek do? PainChek Ltd, based in Sydney, Australia, operates in the Health Care sector, specializing in mobile medical device applications. The company develops and commercializes PainChek Universal, a point-of-care solution combining AI-driven facial recognition for pain assessment in non-verbal patients with the numerical rating scale for self-reporting individuals. Launched following its 2012 IPO, the technology enables objective pain evaluation across diverse care settings, supporting both non-verbal and fluctuating communication abilities. PainChek is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PainChek stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PainChek is -9.92 M AUD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PainChek changed from -9.11 M AUD to -9.92 M AUD, representing a 8.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) PainChek since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s PainChek historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — PainChek

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — PainChek